FDA Inspection
Allergan Sales LLCAllergan Sales LLC – FDA Inspection, Dec 3, 2010
Record Details
This FDA Inspection record concerns Allergan Sales LLC, with an inspection on December 3, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Allergan Sales LLC
- Inspection Date
- December 3, 2010
- Product Type
- Drugs
View Company Profile
ID · 57cc1295-580a-4e82-adee-7c469e66e12e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 699481
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.125(a)Strict control not exercised over labeling issued
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Allergan Sales LLC
8| Date | Classification | Office | Project area |
|---|---|---|---|
| December 12, 2025 | Not classified | Cincinnati District Office | Drug Quality Assurance |
| June 24, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 29, 2019 | VAI | Center for Drug Evaluation and Research | Unapproved and Misbranded Drugs |
| May 20, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 22, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Allergan Sales LLC
- FDA Inspection 1283434 - 2025-12-12
- FDA Inspection 1147251 - 2021-06-24
- FDA Inspection 1097944 - 2019-07-29
- FDA Inspection 978858 - 2016-05-20
- FDA Inspection 943994 - 2015-09-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.